Charles Schwab heads into its May 14 earnings event with an unmistakable insider signal dominating the setup: the company's own founder has been a persistent seller.
Charles R. Schwab, the firm's Founder and Co-Chairman, sold shares on nine separate occasions since late April. The transactions total roughly $48 million in that stretch alone. Over the past 90 days, net insider selling across the company has reached $59 million. That is not a panic trade — the individual transactions are relatively modest in size relative to his overall stake — but the persistence and frequency of the selling is hard to ignore ahead of a scheduled print.
Analysts, meanwhile, remain broadly constructive. JP Morgan maintained its Overweight rating on April 17 and raised its price target to $131. Morgan Stanley kept its Overweight but trimmed its target from $135 to $125 on the same day, after an earlier cut from $148 in early April. UBS, Barclays, and Jefferies all lowered targets during early April while holding positive ratings — a consistent pattern of calibrated optimism rather than conviction buying. The mean street target sits at $115, roughly 30% above SCHW's current price of $88.61. Bulls point to daily average trades of approximately 7.4 million, up 30% year-on-year, a near-$12 trillion client asset base, and improving capital ratios. Bears flag slowing net new asset flows, sensitivity to the rate curve, and the lingering integration drag from the TD Ameritrade acquisition.
Options positioning offers a mild counterweight to the cautious tone. The put/call ratio has eased to 1.19, sitting below its 20-day average of 1.25 — a slight shift toward calls relative to the more defensive posture seen through mid-April when the PCR touched 1.43. That is not a bullish pile-on, but it does suggest the heaviest hedging pressure has faded entering the week of the report. Short interest tells an even quieter story: just 0.81% of the free float is sold short, with borrow costs barely registering at 0.35% and availability remaining comfortably loose. There is no meaningful short-side pressure building here.
The most recent prior earnings event, on April 16, produced a sharp move — the stock fell nearly 8% on the day and dropped more than 11% over the following five sessions. The May 14 print will test whether that reaction was a one-off tied to macro stress or the start of a more durable re-rating, particularly given that the stock has already shed a further 5% over the past month and continues to trade well below the analyst consensus. The gap between where the founder is selling and where the Street says the stock is worth is the central tension the quarter's results will either resolve or deepen.
See the live data behind this article on ORTEX.
Open SCHW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
